Available Until 11/17/2023

Updates in Transplantation: Antimicrobial Stewardship Considerations

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACPE Activity Number: 0204-0000-20-037-H01-P
Release Date: November 17, 2020
Expiration Date: November 17, 2023
Activity Type: Knowledge-based  
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Not Available

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Multi-drug resistant organisms are a problem that continue to grow both in the general population and in the solid organ transplant (SOT) population. It is important to think of antimicrobial stewardship considerations when managing SOT recipients to reduce the risk of development of MDR infections. This includes stewardship both pre- and post-transplant. It is important to understand the downstream effects of using broad spectrum antibiotics pre-transplant and how it can translate to MDROs post-transplant. It is also important to be aware of how to respond to a positive donor culture, whether treatment is indicated or not, as well as how long to treat infections in transplant recipients and manage SOT patients with existing infections pre-transplant. Lastly, there has been several new antibiotics that have come to the market and it is important to understand their role in clinical practice.


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This activity was planned to meet the educational needs of pharmacists managing solid organ transplant recipients with positive donor cultures, multi-drug resistant organisms, and recipients with existing pre-transplant infections.

Learning Objectives

  • Describe antimicrobial stewardship considerations in transplant recipients frequently encountered in clinical practice.
  • Identify various drug-drug interactions between anti-infectives and immunosuppressants.
  • Give examples of personalized infection treatment plans.

Schedule of Activities

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion


  • Erica Maceira, Pharm.D., BCPS, Clinical Pharmacy Specialist - Kidney/Pancreas Transplant, Pharmacy Residency Director; Albany Medical Center, Albany, NY
  • Greg Malat, Pharm.D., FAST, BCPS, Clinical Transplant Pharmacist; Hospital of the University of Pennsylvania, Philadelphia, PA
  • Erin McCreary, Pharm.D., BCPS, Antimicrobial Stewardship/Infectious Diseases Clinical Pharmacist Specialist; University of Pittsburgh Medical Center, Pittsburgh, PA


In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.